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Abstract
Cells can react to environmental changes by transduction of extracellular signals, to produce intracellular responses.
Membrane-impermeable signal molecules are recognized by receptors, which are localized on the plasma membrane of the
cell. Binding of a ligand can result in the stimulation of an intrinsic enzymatic activity of its receptor or the modulation of a
transducing protein. The modulation of one or more intracellular transducing proteins can finally lead to the activation or
inhibition of a so-called ‘effector protein’. In many instances, this also results in altered gene expression. Phosphorylation by
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protein kinases is one of the most common and important regulatory mechanisms in signal transmission. This review
discusses the non-channel transmembrane receptors and their downstream signaling, with special focus on the role of protein
kinases. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cells react to environmental changes, which they
perceive through extracellular signals. These signals
can be either physical (e.g. light, temperature, pres-
sure and electricity) or chemical (e.g. food, hormones
and neurotransmitters). Cells can both sense and
produce signals. This makes it possible that they
communicate with each other. In order to achieve
this, there are complex signal-sensing and -producing
mechanisms in uni- and multi-cellular organisms.
Two groups of chemical signals can be distin-
guished: membrane-permeable and membrane-im-
permeable signals. The membrane-permeable signal
molecules comprise the large family of steroid hor-
mones, such as estrogens, progesterone and andro-
gens. Steroids pass the plasma membrane and bind
to speci¢c receptors, which are localized in the cyto-
plasm or nucleus of the cell. After binding of the
hormone, the receptor undergoes a conformational
change. The receptor is then able to bind to DNA
itself or to proteins which can in turn interact with
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DNA. In general, steroid hormones can directly reg-
ulate gene expression by means of this process [1].
The membrane-impermeable signal molecules include
acetylcholine, growth factors, extracellular matrix
components, thrombin, lysophosphatidic acid, the
yeast mating factors and, for the social amoeba Dic-
tyostelium discoideum, folic acid and cyclic AMP.
They are recognized by receptors, which are localized
on the plasma membrane of the cell. The receptors
are speci¢c for one particular signal molecule or a
family of closely related signal molecules. Upon
binding of their ligands, these receptors transduce
the signals by several mechanisms.
Binding of a ligand to an ion channel receptor can
directly lead to its altered opening, which results in a
changed membrane potential. There are, for instance,
acetylcholine-regulated cation channels in nerve ter-
minals [2]. Alternatively, binding of a ligand may
result in the stimulation of an intrinsic enzymatic
activity of its receptor or the modulation of a trans-
ducing protein. The modulation of one or more in-
tracellular transducing proteins can ¢nally lead to the
activation or inhibition of a so-called ‘e¡ector pro-
tein’. Activity modulations can be achieved by cova-
lent modi¢cations at the molecular level. Among the
most common and important modi¢cations are pro-
tein phosphorylation and dephosphorylation on ser-
ine, threonine or tyrosine residues. Phosphorylation
and dephosphorylation are carried out by kinases
and phosphatases, respectively. As described below,
changes in the phosphorylation state of cellular com-
ponents can alter their properties in several ways. An
interesting yet complicating phenomenon is cross-
talk: intracellular responses to extracellular signals
which in£uence each other. While stimulation of a
cell with one speci¢c ligand may lead to more than
one response, di¡erent signals may lead to an anal-
ogous response via identical components.
The non-channel transmembrane receptors and
their downstream signaling will be discussed, with
special focus on the role of protein kinases. Par-
ticular attention will be drawn to protein kinase C
and mitogen-activated protein kinases. We will
present current knowledge and attempt to place
this into the perspective of possible future develop-
ments.
2. Receptors with enzymatic activity
2.1. Receptor tyrosine kinases
Extracellular signal molecules, like epidermal
growth factor, platelet derived growth factor and in-
sulin bind to receptor tyrosine kinases (RTKs). These
receptors possess one or two intracellular tyrosine
kinase regions (Figs. 1A and 2B). Upon ligand bind-
ing, RTKs auto-phosphorylate. The resulting phos-
photyrosine (PY) residues act as highly selective
binding sites for so-called ‘SH2’ (Src homology do-
main 2)-containing proteins, which transduce the sig-
nal by changing their enzymatic activity or recruiting
other proteins. Among these SH2-containing pro-
teins are Ras-GTPase activating protein (GAP) and
phospholipase C-Q. The latter hydrolyzes phospha-
tidylinositol 4,5-bisphosphate (PIP2) into inositol
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).
IP3 releases Ca2 from intracellular stores; DAG
activates protein kinase C (PKC) (Fig. 1A) [3]. The
SH2-containing adapter molecules, Shc and Grb2
(Src homology and collagen and growth factor re-
ceptor-bound protein 2, respectively), also bind to
phosphorylated RTKs. They are importantly in-
volved in the recruitment of the son of sevenless
(Sos) protein towards the plasma membrane [4].
Sos, which is called a GEF (G-nucleotide exchange
factor) or GNRP (G-nucleotide releasing protein),
stimulates the exchange of GDP for GTP on the
small G-protein Ras, thereby activating it. Ras-
GTP in turn stimulates a protein kinase cascade re-
sulting in mitogen-activated protein kinase (MAPK,
also called ERK, for extracellular signal regulated
kinase) activation (Fig. 1A) [5].
The p85 subunit of phosphatidylinositol 3-kinase
(PI3K) is recruited to PY residues on insulin recep-
tors by IRS (insulin receptor substrate) adapters. The
PI3K p85 subunit is linked to the p110 subunit,
which is able to phosphorylate PIP2. This generates
phosphatidylinositol 3,4,5-trisphosphate (PIP3),
which has several intracellular targets, such as PKC
and protein kinase B (PKB)/Akt. The activation of
PKB/Akt requires phosphorylation by PDK1 (3-
phosphoinositide-dependent protein kinase 1) and
leads to serine phosphorylation and inactivation of
GSK-3 (glycogen synthase kinase-3) (Figs. 1A and
2B) [6,7]. The C-terminus of the cytoplasmic PDZ
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domain protein, Enigma, interacts with Tyr-contain-
ing motifs outside the tyrosine kinase cores of the
Ret RTK and the insulin receptor. Enigma does so
via two of its three so-called ‘LIM domains’ (see
below). The LIM2^Ret and LIM3^insulin receptor
interactions are required for mitogenic signaling
by Ret/ptc2 and receptor endocytosis, respectively
[8,9].
2.2. Receptor-like protein tyrosine phosphatases
Receptor-like protein tyrosine phosphatases
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(RPTPs) contain a variable extracellular domain, a
transmembrane domain and one or two intracellular
tyrosine phosphatase domains (Fig. 1B). Depending
on the RPTP subtype, the extracellular domain ex-
hibits immunoglobulin- and ¢bronectin-like regions
and other sequence motifs involved in cell^cell adhe-
sion [10,11]. The subtype I RPTP CD45 is involved
in the activation of B- and T-lymphocytes. It stimu-
lates the Src-like kinases Lck and Fyn by dephos-
phorylating them [12]. The subtype II RPTPs W
and U have been shown to modulate cell^cell inter-
action. There is some debate on the association of
the cytoplasmic domain of RPTPW with a protein
complex containing cadherin transmembrane adhe-
sion molecules and catenins (which are linked to
the underlying actin cytoskeleton). It appears that
Brady-Kalnay et al. recently reinforced their original
observation, that cadherins are part of such com-
plexes, which has been doubted by other authors
(Fig. 1B) [11,13]. The subtype IV RPTPK tightly
binds to Grb2 (Fig. 1B). Although the precise bio-
logical function of the resulting complex remains to
be determined, it has already been suggested that
binding of Grb2 may inhibit RPTPK activity [14].
The establishment of the exact repercussions of lig-
and binding to RPTPs is currently in progress.
2.3. Receptor serine/threonine kinases
The e¡ects of transforming growth factor-L (TGF-
L) superfamily signal molecules are mediated by re-
ceptors with a cysteine-rich extracellular domain and
a cytoplasmic serine/threonine kinase activity (Figs.
1C and 2BC). In addition to the three TGF-L iso-
forms, this superfamily comprises activins, bone
morphogenetic proteins and other secreted factors.
Members of the TGF-L superfamily have been im-
plicated as being crucial for many speci¢c develop-
mental events in vertebrates, Drosophila melanogaster
and Caenorhabditis elegans ; TGF-L induces growth
arrest in epithelial cells. TGF-L-related factors signal
through type I and type II receptor serine/threonine
kinases, which form a heteromeric complex. Whereas
type II receptors bind TGF-L1 independently, this
ligand does not bind to the type I receptor in the
absence of the type II receptor. In the heteromeric
complex, the type II receptor phosphorylates the type
I receptor [15,16]. A type I^type II complex (but not
type II alone) can associate with the e¡ector Smad3
(for Sma/Mad homolog 3; formerly called hMAD-
3), which is phosphorylated in vitro by type I. A
complex of Smad3 and its homolog Smad4 is
thought to ¢nally function as a transcriptional regu-
lator of downstream genes in the nucleus (Fig. 1C)
[17]. The Smad2 protein has recently been reported
to act as a common positive e¡ector of both receptor
serine/threonine kinases and RTKs; this provides
one of the many examples of cross-talk during signal
transduction from the cell surface to the nucleus [18].
2.4. The two-component regulatory system: histidine
kinases
Prokaryotic organisms commonly employ the two-
component regulatory system; homologous path-
ways have recently been identi¢ed in eukaryotes, in-
Fig. 1. Structures of cell surface receptors and schematic diagrams of their downstream signaling. In plasma membrane receptors, the
N-terminus is generally extracellular, while the C-terminus is cytoplasmic. Main structural features are indicated. Open ovals, cysteine-
rich regions; shaded boxes, protein kinase catalytic domains; semi-circles, immunoglobulin-like regions; horizontally striped boxes, ¢-
bronectin-like regions. Double and triple arrows represent multiple signal transduction steps (activation via second messenger forma-
tion or a cascade). (A) Receptor tyrosine kinases (RTKs). Structures of the EGF (epidermal growth factor), PDGF (platelet derived
growth factor) and Ins (insulin) receptor subclasses. The protein tyrosine kinase domain of the PDGF receptor contains an insertion
sequence. (B) Receptor-like protein tyrosine phosphatases (RPTPs). Structures of RPTPW and RPTPK. Vertically striped box, speci¢c
cell^cell interaction domain; solid boxes, protein tyrosine phosphatase catalytic domains. Some RPTPs contain a single phosphatase
domain. (C) Receptor serine/threonine kinases. Structure of the activin/TGF-L type II receptor (TGFR II). (D) Histidine kinases. The
Saccharomyces Sln1p His K (histidine kinase) contains an extracellular input region (double diagonally striped box) and an intracellu-
lar transmitter module (diagonally striped box) and receiver domain (open box). (E) Transmembrane guanylyl cyclases (GCs). Dotted
box, protein kinase homology domain; black and white box, cyclase catalytic domain. (F) Cytokine receptors. Solid oval, membrane-
proximal JAK binding box1/box2 motifs. (G) Integrins. Structures of L and K subunits. The extracellular ligand binding region is
made up from both subunits in K/L heterodimers. (H) G-protein-coupled receptors (GPCRs). The C-terminal intracellular domains of
GPCRs greatly vary in sequence and length. For further abbreviations, details and references, see main text.
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cluding Saccharomyces cerevisiae, Arabidopsis thali-
ana, Neurospora crassa and Dictyostelium discoideum.
The prototypical two-component pathway consists of
two proteins: a protein histidine kinase (also called
sensor kinase) and a response regulator. The N-ter-
minal part of the histidine kinase functions as an
input domain, detecting extracellular signals directly
or via an upstream receptor. The C-terminal portion
contains the transmitter module. This domain in-
cludes a histidine residue at which the protein auto-
phosphorylates. The response regulator has a re-
ceiver domain, which catalyzes the transfer of the
phosphoryl group from the histidine of the sensor
kinase to a conserved aspartate residue on the re-
ceiver. The phosphorylation state of the regulator
modulates the activity of its output domain, which
is often involved in the regulation of transcription
[19]. Hybrid histidine kinases combine an input re-
gion, a transmitter module and a response regulator
in one molecule. Sensing domains can be integrated
within the histidine kinase or contained within a sep-
arate protein [20]. Histidine kinases are very distinct
from the superfamily of conventional protein serine/
threonine and tyrosine kinases.
There are complex signal transduction pathways
built from two-component circuit elements: one im-
portant motif is the His^Asp^His^Asp phosphorelay.
One of the most striking examples is the Sln1p^
Ypd1p^Ssk1p pathway, which governs osmoregula-
tion in the budding yeast S. cerevisiae. The trans-
membrane protein Sln1p contains an extracellular
input region and cytoplasmic histidine kinase and
receiver domains (Fig. 1D); the cytoplasmic Ssk1p
protein has a receiver domain. Ypd1p binds to
both Sln1p and Ssk1p and mediates the phosphore-
lay. During this phosphorelay, a phosphate is ¢rst
transferred from a His in the Sln1p kinase domain
to an Asp in its receiver domain, then to a His in
Ypd1p, and ¢nally to an Asp in Ssk1p. Ssk1p in turn
modulates the activity of the downstream Ssk2p/
Ssk22p^Pbs2p^Hog1p (for high osmolarity glycerol
response) MAPK cascade (Fig. 1D) [21^23].
2.5. Guanylyl cyclases
Guanylyl cyclases (GCs) usually serve as receptors
that produce cyclic GMP (cGMP) from GTP in re-
sponse to ligand binding. In general, the plasma
membrane forms of GC possess a variable extracel-
lular domain, a single transmembrane domain, an
intracellular protein kinase homology domain
(KHD) and an intracellular cyclase catalytic domain
(Fig. 1E). The known ligands for mammalian trans-
membrane GCs fall into two families: (1) the Esche-
richia coli heat-stable enterotoxins and their endoge-
nous homologs; and (2) the natriuretic peptides, such
as the vasorelaxing ANP (atrial natriuretic peptide).
Binding of ATP to the KHD is believed to potentiate
the activation of the GC catalytic domain upon ANP
binding; protein kinase activity is, however, not re-
quired [24,25]. ANP is able to inhibit the prolifera-
tion of mesangial cells in a cGMP-dependent man-
ner. Interestingly, it does so by inducing the
expression of the downstream MAPK-speci¢c phos-
phatase MKP-1, which inhibits MAPK [26]. Intra-
cellular cGMP can activate cGMP-dependent protein
kinase (cGK or PKG) I or II. The action of PKG I
can then, for instance, reduce cytosolic Ca2 levels in
several cell types (Fig. 1E) [27].
3. Receptors without enzymatic activity
3.1. Cytokine receptors
Many cytokine receptors lack intrinsic catalytic
domains. These receptors consist of a conserved ex-
tracellular domain, a transmembrane region and an
intracellular domain containing the membrane-prox-
imal so-called ‘box1’ and ‘box2’ motifs (Fig. 1F).
Cytokine receptors couple ligand binding to tyrosine
phosphorylations by using non-covalently associated
protein tyrosine kinases: the Janus kinases (JAKs).
These JAKs bind to the box1 and box2 motifs. The
known members of the JAK family (JAK1, JAK2,
JAK3 and TYK2) have a C-terminal kinase domain,
which is immediately preceded by a pseudo-kinase
domain; several other homologous regions in the
N-terminal sequences have been implicated in inter-
actions with various cytokine receptors. Among the
signaling proteins that are recruited to the receptor
complex and tyrosine phosphorylated are the cyto-
plasmic signal transducers and activators of tran-
scription (STATs) (Fig. 1F). Phosphorylated STATs
dimerize through reciprocal SH2^PY interactions
and translocate to the nucleus, where they bind to
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speci¢c DNA elements and stimulate transcription.
STATs are not only activated by cytokine receptors,
but also by RTKs and the so-called ‘serpentine’ an-
giotensin II receptor (see below). There is evidence
that STATs are at least partly modulated by the
Ras^MAPK pathway; conversely, JAK2 has been
shown to activate MAPK through the upstream kin-
ase Raf-1 [28^30].
Recently, the STAT genes dstA and stat92E were
cloned from Dictyostelium and the Drosophila fruit
£y, respectively. Like its metazoan counterparts, the
Dictyostelium STAT protein functions via a recipro-
cal SH2^PY interaction; it is activated by a serpen-
tine cyclic AMP receptor. In the £y, the STAT92E
protein is believed to be activated by a JAK homolog
encoded by hopscotch. In both model organisms,
pathways employing STATs have been implicated
in developmental decisions [31,32].
3.2. Integrins
Integrins are the major type of cell surface recep-
tors that bind to ligands on adjacent cells or in the
extracellular matrix. Integrins are heterodimers of K
and L subunits, which consist of a large extracellular,
a single transmembrane and a short cytoplasmic do-
main (Fig. 1G). Most integrins bind extracellular ma-
trix components like ¢bronectin, collagen or vitro-
nectin. Upon ligand binding, the integrins cluster.
This leads to the formation of focal adhesions, where
integrins link to intracellular cytoskeletal complexes.
The cytoplasmic domains of integrins do not have
intrinsic enzymatic activities and appear to activate
intracellular tyrosine kinases by clustering [33,34].
Integrin engagement elevates focal adhesion kinase
(FAK) PY levels and FAK-associated tyrosine kin-
ase activity. The non-receptor tyrosine kinase Src is
thought to associate with an ‘auto-phosphorylated’
form of FAK and to phosphorylate FAK in turn.
Both FAK and Src phosphorylate the adapter mol-
ecule Shc at multiple sites to create SH2 binding sites
for the Grb2 adapter protein; phosphorylation of a
FAK tyrosine residue near the C-terminus (by a Src
family kinase) also promotes Grb2 binding. This pro-
vides a link to the proliferative Ras^MAPK cascade
(Fig. 1G). Certain levels of integrin-dependent signal-
ing to MAPK can also be achieved in the absence of
either Src family or FAK activity [35^37].
3.3. G-protein-coupled receptors
A third, large group of receptors without intrinsic
catalytic activity is that of the G-protein-coupled re-
ceptors (GPCRs). The GPCRs include adrenergic,
muscarinic, serotonin, dopamine, adenosine, angio-
tensin II, thrombin, extracellular Ca2, lysophospha-
tidic acid (LPA), yeast mating factor and Dictyoste-
lium cyclic AMP receptors [38^41]. These receptors
all contain seven transmembrane regions; they are,
therefore, also referred to as serpentine receptors.
The N-termini of GPCRs are extracellular, while
the C-termini are found in the cytoplasm (Fig. 1H).
Upon binding of its ligand, a GPCR generally inter-
acts with a heterotrimeric guanine-nucleotide binding
protein (G-protein). GPCRs like the L2-adrenergic
receptor can be desensitized by uncoupling from
their G-proteins and internalization. This process is
initiated by phosphorylation of the agonist-occupied
receptor. Strikingly, GPCR endocytosis is required
for the L2-adrenergic receptor-dependent activation
of MAPKs [42].
Heterotrimeric G-proteins consist of three sub-
units: K, L and Q. The K subunit binds the G-nucleo-
tide, contains a GTPase activity and modulates e¡ec-
tor enzymes. The L/Q complex enhances receptor
interaction with K subunits and also regulates a ple-
thora of e¡ectors directly. Upon ligand binding to a
GPCR, the interacting G-protein exchanges bound
GDP for GTP and undergoes a conformational
change. This results in the dissociation of the GTP-
bound K subunit from the L/Q subunit complex. The
K and L/Q subunits are then able to activate or inhibit
enzymes which produce an intracellular signal. The
intrinsic GTPase activity of the K subunit terminates
its signaling. The K subunit dissociates from the tar-
get molecule to reunite with the L/Q complex, so that
the resting state is reached again [43]. RGS (regula-
tors of G-protein signaling) family members such as
GAIP (G alpha interacting protein) and RGS4 have
been identi¢ed as GAPs for GK subunits [44,45].
Several lines of evidence suggest that RGS can switch
o¡ signaling through L/Q complexes by modulating
the activity of the K subunits [46].
The activation of G-proteins leads to the regula-
tion of channels and second messenger-producing
enzymes such as adenylyl cyclase and phospholipase
C. Active adenylyl cyclase (AC) produces the second
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messenger cyclic AMP (cAMP) from ATP. All nine
cloned mammalian ACs can be activated by stimu-
latory K subunits (GKs) ; several are modulated by
inhibitory K subunits (GKi) and/or GL/Q complexes.
cAMP can activate the cAMP-dependent protein
kinase (cAK or PKA) (Fig. 1H), which in turn phos-
phorylates a wide range of substrates, such as the
cAMP responsive element binding protein (CREB).
When PKA translocates to the nucleus and phos-
phorylates CREB, the latter is stimulated to regulate
gene transcription. CREB does so by binding to the
cis-acting cAMP responsive elements of several genes
[47,48].
There are three mammalian phospholipase C
(PLC) isoform families: PLC-L, PLC-Q and PLC-N.
Members of the PLC-L family are activated by ser-
pentine receptors and PLC-Q isoforms are stimulated
through RTKs. The mechanisms involved in PLC-N
activation have been poorly understood for a long
time; it was only recently reported that PLC-N1 is
an e¡ector for GKh-dependent GPCR signaling
[49]. All known forms of PLC-L are stimulated to
various extents by the GKq family of K subunits.
PLC-L2 and -L3 are also activated by G-protein L/Q
subunits. There is cross-talk between AC and PLC
pathways: PKA can speci¢cally inhibit GL/Q-stimu-
lated PLC-L2 (Fig. 1H) [50]. Active PLCs catalyze
the hydrolysis of PIP2 to generate the second mes-
sengers IP3 and DAG. On the endoplasmatic reticu-
lum, there are IP3-speci¢c receptors, which regulate
Ca2 release into the cytoplasm [51]. Cytosolic Ca2
can modulate the activity of serine/threonine Ca2/
calmodulin-dependent kinases (CaMKs) via calmo-
dulin. Neuronal CaMK is, for instance, stimulated
to phosphorylate and activate tyrosine hydroxylase,
which is the rate-limiting enzyme in the synthesis of
catecholamine neurotransmitters [52]. One of the
other e¡ects mediated by Ca2 is the regulation of
the conventional PKC isoforms (see below). In-
creased intracellular Ca2 promotes binding of
Ca2 to inactive PKC in the cytosol. This leads to
membrane-association of PKC, which then binds
DAG. Binding of DAG and Ca2 increases the af-
¢nity of PKC for phosphatidyl-serine, resulting in
a tighter association of PKC with the membrane
and full physiological activation of PKC (Fig. 1H)
[53].
Mitogenic GPCRs, such as those for the lipid mes-
senger LPA, can also activate the Ras^MAPK cas-
cade. At least four G-protein mediated signaling
pathways, involved in the action of LPA, have
been identi¢ed: (1) stimulation of PLC; (2) inhibi-
tion of AC; (3) activation of Ras and the down-
stream Raf^MAPK pathway; and (4) remodeling
of the actomyosin cytoskeleton in a GK12/GK13-
and Rho-dependent manner [54]. Gq links the recep-
tor to PLC, while the inhibition of AC is mediated
by Gi [55,56]. The activation of the Ras^MAPK cas-
cade involves GiL/Q subunits, tyrosine kinase activity
and recruitment of the adapter protein Grb2 (and
therefore Sos, etc.) to the plasma membrane (Fig.
1H) [57^59]. The p110 PI3K Q subunit is thought
to be involved in connecting Gi to the Ras^MAPK
cascade in COS-7 cells [56,60]. A recent paper by
Luttrell et al. [58] suggests that Src family tyrosine
kinases, Shc and Grb2 link LPA receptors and GiL/Q
subunits to this cascade in COS-7 cells ; the authors
propose that, during this process, the epidermal
growth factor receptor is used as a sca¡old. Data
by Kranenburg et al. [59] and Roche et al. [61], on
the other hand, indicate that Src and Shc are not
involved in linking LPA receptors and Gi to the
Ras^MAPK pathway in ¢broblasts and COS-7 cells.
The results of Kranenburg et al. suggest that a 100-
kDa tyrosine phosphorylated protein^Grb2 complex,
together with an upstream non-Src tyrosine kinase
and PI3K, couples Gi to Ras^MAPK activation. Ac-
tomyosin cytoskeleton remodeling results from ser-
ine/threonine phosphorylation and inhibition of my-
osin light chain phosphatase [62].
After years of unsuccessful e¡orts, several groups
have recently reported the isolation of cDNA clones
encoding putative functional LPA receptors, with
predicted molecular masses of approximately 40
kDa. The most recent evidence now strongly sub-
stantiates that LPA is indeed able to exert multiple
actions in its target cells via these GPCRs. It has
been shown that LPA speci¢cally activates the Sac-
charomyces pheromone response MAPK pathway in
yeast cells functionally expressing the human puta-
tive LPA receptor Edg-2 (Vzg-1) [40]. In addition,
heterologous expression of mouse VZG-1 in neuro-
nal and non-neuronal cells is both necessary and
su⁄cient in mediating multiple e¡ects of LPA [41].
BBAMCR 14438 1-2-99
P.W. Schenk, B.E. Snaar-Jagalska / Biochimica et Biophysica Acta 1449 (1999) 1^248
4. Protein kinases
4.1. Phosphorylation: a type of protein modi¢cations
One of the common scenarios in signal transduc-
tion is the modi¢cation of proteins leading to the
alteration of their properties (e.g. activity). There
are several types of modi¢cations. They create new
forms of amino acid residues and can thus expand
the repertoire of chemistry that proteins are able to
perform.
Isoprenylation (mostly farnesylation and geranyl-
geranylation), myristoyl and palmitoyl lipidation and
methylation are often important for correct protein
localization [63^67]. In several cases, glycosylation
modulates the activity of a protein. The reversible
linkage of N-acetylglucosamine to serines and threo-
nines is also thought to be important for the assem-
bly of protein complexes and to act as an antagonist
of phosphorylation: glycosylation and phosphoryla-
tion may be competing for the same sites on many
proteins [68,69].
Phosphorylation is an extremely important type of
modi¢cation. When a molecule is phosphorylated,
the Q-phosphate of ATP is transferred onto it by a
kinase. Phosphorylation of a protein can either acti-
vate or inhibit it. The AP-1 (Fos/Jun) transcription
factor cJun contains phosphorylation sites at its N-
terminus and near the downstream DNA binding
region. N-terminal phosphorylation (by MAPK fam-
ily members) is involved in cJun activation, whereas
phosphorylation near the DNA binding site (by
GSK-3) silences cJun [70]. Phosphorylation of tyro-
sine residues can also create highly selective docking
sites for SH2 or other PY binding domain containing
proteins [3]. The presence of protein phosphatases
allows switching between active and inactive states
of proteins and their complexes: they dephospho-
rylate their targets by removing phosphate modi¢ca-
tions. Although many phosphatases have a wide
range of substrates, speci¢c protein phosphatases
have also been described recently (see below).
4.2. Conserved protein kinase catalytic domains: some
mechanistic aspects
Enzymes belonging to the superfamily of protein
kinases are related by virtue of their kinase catalytic
domains [71]. In S. cerevisiae (for which the complete
genome has been sequenced) alone, there are 113
conventional protein kinase genes. It is estimated
that there are more than a thousand human protein
kinases [72]. For many years, the kinase proteins
have been divided into two classes: kinases that
phosphorylate serine and/or threonine residues and
kinases that phosphorylate tyrosine amino acids.
The enzymes were grouped into families and sub-
families, solely on the basis of sequence alignments.
After the elucidation of several crystal structures of
protein kinases in the active and/or inactive state,
they are now also structurally and mechanistically
analyzed and compared [73]. Although serine/threo-
nine and tyrosine kinases di¡er in the residues to
which they transfer phosphate, their catalytic do-
mains appear to have many common features and
a basically identical mode of action [74].
Histidine kinases were originally identi¢ed in pro-
karyotes and are very distinct from the superfamily
of conventional protein kinases described in this sec-
tion. They auto-phosphorylate on histidine residues
and are involved in the phosphorylation of aspartate
amino acids in their targets. The eukaryotic histidine
kinases include the Saccharomyces Sln1p, Arabidopsis
ETR1 and CKI1, and Dictyostelium DokA, DhkA
and DhkB proteins [75,76]. Although the mammalian
mitochondrial branched-chain K-ketoacid dehydro-
genase and pyruvate dehydrogenase kinases phos-
phorylate their target proteins on serines, they struc-
turally belong to the histidine kinases as well [77].
The kinase catalytic domain of the members of the
superfamily of conventional protein kinases consists
of 250^300 amino acids. This domain is further di-
vided into twelve smaller subdomains (indicated by
Roman numerals; Fig. 2A). The subdomains are
very rarely interrupted by large amino acid insertions
and contain characteristic patterns of conserved res-
idues. The overall kinase domain folds into a two-
lobed structure. The smaller N-terminal lobe (subdo-
mains I^IV) is primarily involved in anchoring and
orienting ATP. The larger C-terminal lobe (subdo-
mains VIa^XI) is largely responsible for binding
the substrate and initiating phosphotransfer. The
subdomain V residues span the two lobes. The
deep cleft between the two lobes is the site of catal-
ysis. There is £exibility between the two lobes in
response to substrate binding, via a so-called ‘in-
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duced ¢t mechanism’: the transition from open (in-
active) to closed (active) conformations proceeds by
a de¢ned route [73].
Subdomain I contains the consensus motif
GxGxxGxV, in which the second glycine (G) is in-
variant. This region can act as a £exible clamp, that
anchors the non-transferred phosphates of ATP.
Subdomain II includes an invariant lysine, which is
essential for maximal kinase activity. This lysine is
almost immediately preceded by an alanine residue
(AxK motif). This region importantly contributes to
the anchoring and orienting of ATP. The invariant
lysine residue is localized by interaction with the
nearly invariant glutamate (E) amino acid in subdo-
main III. The subdomains IV and V contain no in-
variant or nearly invariant residues.
Subdomain VIa seems to act mainly as a support
structure. Subdomain VIb includes invariant aspar-
tate and asparagine amino acids within a
HRDLKxxN or corresponding motif (the sequence
mentioned here represents the consensus for serine/
threonine kinases: see below). The loop containing
the invariant aspartate (D) has been named the cata-
lytic loop, since this residue is the most likely candi-
date for being the catalytic base. The lysine (K) in
the loop contacts the ATP Q-phosphate and may help
facilitate phosphotransfer. The side chain of the in-
variant asparagine (N) and the invariant aspartate
(D) amino acid of the highly conserved DFG triplet
in subdomain VII are involved in binding ATP che-
lating metal. Subdomain VIII includes the APE mo-
tif ; this subdomain folds into a loop, which faces the
catalytic cleft. The nearly invariant glutamate (E)
forms an ion pair with an arginine (R) in subdomain
XI, thereby stabilizing the C-terminal lobe.
Subdomain IX contains a nearly invariant aspar-
tate (D) residue within a DxWxxG consensus motif.
This aspartate amino acid stabilizes the catalytic
loop. Subdomain X is poorly conserved. In the
MAPK family member ERK2, conformational
changes in the so-called ‘MAPK insertion region’
(at the C-terminus of subdomain X) are thought to
have a regulatory role [78]. As already mentioned,
subdomain XI assists in stabilization of the large
kinase domain lobe, through interaction with subdo-
main VIII (for consensus motifs, see Fig. 2A) [71,73].
The region between the DFG and APE motifs
(subdomains VII and VIII, respectively) has been
Fig. 2. (A) Typical 300 amino acid protein serine/threonine kin-
ase catalytic domain. The 12 conserved subdomains are indi-
cated by Roman numerals. Consensus sequences found in the
subdomains are shown with invariant or nearly invariant resi-
dues in bold. In conventional protein tyrosine kinases, the Kxx
part of the motif in subdomain VIb is replaced by RAA or
AAR. (B) Schematic diagram of some major families of protein
kinases. The kinase catalytic domains are shaded. Where applic-
able, monomeric forms of the proteins are shown. The AGC
group includes the cyclic nucleotide-dependent kinase (PKA,
PKG) and PKC families. For PKA, the catalytic subunit is
shown. The cGMP binding domain of PKG and the regulatory
domain of PKC are diagonally striped. The autoregulatory do-
main (which is able to bind Ca2/calmodulin) of CaMK is also
diagonally striped. The CMGC group contains the CDK,
MAPK/ERK and GSK-3 families. The regulatory serine (S),
threonine (T) and tyrosine (Y) amino acids are indicated. The
conventional protein tyrosine kinase (PTK) group includes the
Src family and the EGFR RTK family. The regulatory tyrosine
(Y) residue of Src and its SH2 and SH3 domains are indicated.
The N-terminal myristoyl (Myr) modi¢cation is required for its
membrane attachment. The RTKs contain ligand binding ex-
tracellular domains (double diagonally striped) and transmem-
brane (TM) domains. Among the group of ‘other’ kinases are
the MEK/Ste7p, Raf and activin/TGF-L receptor (TGFR) fami-
lies and the LIM kinases. The regulatory SxxxxxS/T motif of
the MEK/Ste7p proteins and the Ras binding domain (RBD) of
the Raf proteins are indicated. The activin/TGF-L receptors
have ligand binding extracellular domains (double diagonally
striped) and transmembrane (TM) domains. Finally, the LIM
and PDZ domains of the LIM kinases are shown. For further
details and references, see main text.
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de¢ned as the activation segment. The residues, that
lie in the central part of this segment, are often well-
conserved among the members of individual protein
kinase families. This is, for instance, the case for the
TxY motif of the MAPK family: this is the site on
which the family members are phosphorylated by
their kinase regulators [78,79]. In the conformation
of inactive kinases, interactions between the DFG
region and the N-terminal lobe keep the lobes
open. Modi¢cation of the segment between the
DFG and APE motifs is thought to trigger the cor-
rect disposition of the two kinase domain lobes for
activation. The interaction with the substrate also
depends upon a de¢ned conformation of the activa-
tion segment. There is thus a crucial role for this
segment in substrate recognition [73]. Obviously,
the serine/threonine or tyrosine residue undergoing
phosphorylation and the surrounding kinase and
substrate residues in£uence the catalytic event as
well. Especially for serine/threonine protein kinases,
many substrate sequence elements, which direct e⁄-
cient phosphorylation, have been identi¢ed. These
are often referred to as speci¢city determinants,
which have been reviewed extensively by Pinna and
Ruzzene [80]. Moreover, it is well possible that the
three-dimensional structure of the substrate protein
is at least as important in many instances.
Phylogenetic trees, derived from an alignment of
catalytic domains, served as the basis for a classi¢-
cation of protein kinases by Hanks and Hunter [71].
They have divided the superfamily of eukaryotic pro-
tein kinases into ¢ve groups. It turned out that the
members of each group not only show similarities in
the catalytic domain, but also in other characteris-
tics: they are often similar in overall structural top-
ology (Fig. 2B) and frequently display analogous
modes of regulation and substrate speci¢cities. We
will only present a brief overview of these groups
of protein kinases; links to more detailed informa-
tion can, for instance, be found in the Protein Kinase
Resource on the World Wide Web (http://
www.sdsc.edu/Kinases/pk_home.html) [81].
4.3. The AGC group of protein kinases
The AGC group serine/threonine protein kinases
tend to be basic amino acid-directed enzymes
[71,80]. Many of these kinases are activated upon the
release of second messengers. The AGC group in-
cludes the cyclic nucleotide regulated protein kinase
(PKA, PKG) family, the PKC family (see below), the
‘RAC’ (PKB/Akt) family, the GPCR kinase family
and the ribosomal S6 protein kinase family. The
cAMP activated mammalian PKA enzymes are
tetramers composed of two regulatory (cAMP bind-
ing) and two catalytic (kinase) subunits [82]. GPCR
kinases such as the L-adrenergic receptor kinase are
only active when a ligand induced conformational
change of the substrate receptor has occurred [42].
The PIP3-dependent p70 S6 protein kinase (S6K) is
stimulated by means of serine/threonine phosphoryl-
ation by upstream kinases; S6K can in turn phos-
phorylate the 40S ribosomal protein S6. Only in
1997, it has been demonstrated that S6K is an in
vivo and in vitro substrate for the recently identi¢ed
enzyme PDK1 (which also phosphorylates PKB/
Akt). In a more recent paper, Weng et al., however,
suggested that in vivo S6K activity could be more
closely related to another phosphorylation event
[6,83^86].
4.4. The CaMK group of protein kinases
The CaMK group serine/threonine protein kinases
tend to be basic amino acid-directed as well [71,80].
Regulation via second messenger pathways is also
common for this group. The CaMK group includes
the Ca2/calmodulin-dependent kinase (CaMK) and
SNF1/AMPK families. Ca2 is mainly responsible
for the regulation of CaMKs. It can bind to the
so-called ‘EF-hands’ of calmodulin, which in turn
regulates CaMK activity by direct interaction (Fig.
2B) [52,87]. The myosin light chain kinases and the
plant calcium-dependent protein kinases (which con-
tain an intrinsic calmodulin-like domain) belong to
the family of CaMKs too [88,89]. The SNF1/AMPK
family contains the yeast and plant SNF1 and verte-
brate AMPK homologs. The latter are activated by
elevated AMP levels. The SNF1/AMPK proteins are
thought to function in cellular responses to environ-
mental changes, by regulating key metabolic path-
ways [90]. An additional important member of the
CaMK group is MAPKAP2 (MAPK activated pro-
tein kinase 2).
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4.5. The CMGC group of protein kinases
The CMGC group serine/threonine kinases are not
regulated by second messengers, but act further
downstream protein kinase cascades. These kinases
commonly exhibit regulatory phosphorylation sites
in the activation segment (Fig. 2B). The CMGC
group includes the CDK (cyclin-dependent kinase)
family, the MAPK/ERK family, the GSK-3 family
and the Clk (Cdc-like kinase) family. The members
of the CDK and MAPK/ERK families are proline-
directed, while kinases belonging to the GSK-3 fam-
ily are acidophilic [80]. The CDKs are involved in the
control of cell cycle progression in eukaryotes. They
are the catalytic subunits in complexes with cyclin
regulatory subunits. Phosphorylation of a conserved
threonine residue is universally required for CDK
activation [91,92]. Almost all members of the
MAPK/ERK family have a TxY activation motif in
the region between the subdomain VII DFG and
subdomain VIII APE consensus sequences. The
MAPK family and its subfamilies will be discussed
in more detail below. The GSK-3 family contains the
GSK-3 and casein kinase II isoforms. Phosphoryla-
tion of a speci¢c tyrosine residue is a requisite for
activation of GSK-3 [93]. The mammalian, Drosophi-
la, plant and Dictyostelium GSK-3 homologs have all
been implicated to have an important role in devel-
opment [88,94]. The multifunctional enzyme casein
kinase II (CK2) is required for viability and cell cycle
progression. The constitutively active holoenzyme
consists of two catalytic (K and/or KP) and two reg-
ulatory (L) subunits. CK2 phosphorylates more than
160 substrates, among which are several transcrip-
tion factors, the tumor suppressor protein p53 and
the HIV-1 Rev gene product. The regulation of CK2
is just beginning to be elucidated. Di¡erent domains
of the L subunits are involved in positive and nega-
tive control of the catalytic subunits. An acidic clus-
ter in the N-terminal region of the L subunit is im-
plicated in down-regulation, which can be
counteracted by polybasic peptides, such as histones
[95^97]. HIV-1 Rev (which contains an arginine-rich
cluster) has recently been shown to be a potent in
vitro activator of CK2 as well [98].
4.6. The conventional protein tyrosine kinase group
The group of the conventional protein tyrosine
kinases (PTKs) di¡ers from all the other groups in
that the members exclusively phosphorylate tyrosine
residues. PTKs are often involved in the transduction
of growth and di¡erentiation signals in metazoans.
The most important sequence di¡erences between the
serine/threonine and conventional tyrosine kinases lie
within the catalytic loop and the activation segment.
A sequence according to the HRDLKxxN motif in
the catalytic loop (subdomain VIb) indicates serine/
threonine speci¢city; HRDLRAAN and
HRDLAARN are the consensus sequences indicative
of conventional non-receptor PTKs and RTKs, re-
spectively. In the activation segment, there is a con-
served threonine in serine/threonine kinases; in
PTKs, the equivalent residue is a proline. This could
create a more open site for the larger tyrosine sub-
strate residue to be accommodated [73,74].
Genes for hundreds of mammalian PTKs have
been cloned [99]. Nine non-receptor PTK and thir-
teen RTK families have been de¢ned; several addi-
tional PTKs do not appear to belong to any of these
families [71,100]. Among the non-receptor PTKs are
the Src, Csk, JAK and FAK families (see previous
sections). Src and other kinases of its family have an
SH2 and an SH3 domain adjacent to their catalytic
domain. The kinase activity of Src is repressed when
a C-terminal tyrosine residue (Fig. 2B) is phospho-
rylated by Csk (C-terminal Src kinase); this creates a
binding site for the Src SH2 domain. An intramolec-
ular PY^SH2 interaction locks the kinase in its in-
active conformation. Src can be activated by desta-
bilization of this PY^SH2 interaction: this can be
achieved by dephosphorylation of the C-terminus
or binding of the SH2 domain to extramolecular sites
[3,100].
4.7. The group of ‘other’ protein kinases
The protein kinases falling outside the four major
groups are combined in the group of ‘other’ kinases.
The individual members within de¢ned families of
this ‘other’ group are clearly related to one another;
it is, however, di⁄cult to group these families into a
larger category. The group of ‘other’ kinases includes
the MEK/Ste7p family, the MEKK/Ste11p family,
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the PAK/Ste20p family, the Raf family, the activin/
TGF-L receptor family, the £owering plant receptor
kinase family, the casein kinase I family and the LIM
kinases.
The members of the ¢rst four families function in
the MAPK family protein kinase cascades (Fig. 3).
The mammalian MEK1a (MAPK/ERK kinase 1a)
and Saccharomyces Ste7p isoforms are activated by
means of phosphorylation on conserved serine/threo-
nine residues by Raf-1 and Ste11p, respectively (Fig.
2B) [101]. MAPK kinases, like MEK1a, are able to
phosphorylate both threonine and tyrosine residues
on MAPKs by themselves; MAPKKs are therefore
called dual speci¢city kinases [102]. These dual spe-
ci¢city kinases have a lysine (K) within the catalytic
loop motif in subdomain VIb, which is otherwise
indicative of serine/threonine speci¢city. Mammalian
MEKKs (MEK kinases) activate the MAPK family
SAPKs or JNKs (stress-activated protein kinases or
cJun N-terminal kinases) via the dual speci¢city kin-
ase SEK1 (SAPK/ERK kinase 1) [79]. MEKK1 also
binds the small G-protein Ras and kinase-inactive
MEKK1 inhibits ERK activation in response to
EGF. The PAKs (p21-activated kinases) are acti-
vated by interaction with the small Rho family G-
proteins Rac1 and Cdc42Hs. PAKs are able to me-
diate the activation of SAPKs, independent of
MEKKs [103]. The Saccharomyces Ste20p protein
phosphorylates Ste11p in vitro [104,105]. The Raf
family kinases (which include the Arabidopsis CTR1
protein) have a large N-terminal section, which is
involved in regulation of the kinase activity and in-
teraction with other proteins. Mammalian Raf-1 can
directly bind Ras and Rap1a at its Ras binding do-
main (Fig. 2B). Ras-GTP is involved in the trans-
location of Raf-1 to the plasma membrane, which
is the ¢rst step required for full Raf activation
[106,107]. Ras-GTP is assumed to displace half of a
so-called ‘14-3-3 dimer’ from the N-terminus of in-
active Raf-1. After phosphorylation of Raf-1, the 14-
3-3 dimer is then proposed to stabilize the active
conformation of Raf-1 by binding to newly phos-
phorylated sites [108].
Many members of the £owering plant (putative)
receptor kinase family have been identi¢ed recently.
The physiological functions of most of these kinases
are presently unknown. This does not apply to the
Brassica S-receptor kinase: its activity is required for
self-incompatibility [88,109]. The casein kinase I
(CK1) isozymes are a family of constitutively active
Fig. 3. Schematic diagram of some major MAPK family pathways in Saccharomyces (left) and vertebrates (middle). Generic names of
the transduction components are indicated on the right. Dotted arrows represent interactions, which have not been fully elucidated.
The double arrow represents multiple steps. For abbreviations, details and references, see main text.
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monomeric enzymes, which are phosphate-directed.
CK1 is an exceptional protein kinase, in that its pri-
mary structure contains neither the APE motif in
subdomain VIII, nor the interacting arginine (R) in
subdomain XI (Fig. 2A). Its three-dimensional fold-
ing is, however, still very similar to that of other
protein kinases [80,110]. CK1 has been implicated
in the pathogenesis of Alzheimer’s disease, through
hyperphosphorylation of the d protein (which is the
major component of the abnormal paired helical ¢l-
aments); it also phosphorylates a proteolytic frag-
ment of the disease associated protein presenilin-2
in vitro and in vivo [111,112]. In lower eukaryotes,
individual CK1 isoforms are involved in the regula-
tion of repair pathways, cell proliferation and mor-
phogenesis [113,114].
When Hanks and Hunter [71] de¢ned their classi-
¢cation of protein kinases, the ¢rst LIM kinases
(LIMKs) were just being discovered. They contain
two N-terminal LIM domains, an internal PDZ do-
main (see below) and a C-terminal protein kinase
domain (Fig. 2B) with an unusual catalytic region
(subdomain VIb: HRDLNSHN); a similar catalytic
region (HRDLTSKN) is found in the human and rat
testis-speci¢c protein kinase TESK1. These kinases
are most related to members of the activin/TGF-L
receptor family. Their catalytic activity is towards
serine/threonine residues [115,116]. LIM domains
contain a cysteine-rich motif that was ¢rst identi¢ed
in the products of the C. elegans lin-11, the rat ISL1
and the C. elegans mec-3 genes; the term LIM is a
combination of the ¢rst letters of the gene names.
LIM domains are de¢ned by a conserved pattern of
cysteine, histidine or alternative metal-coordinating
residues; they coordinate two zinc ions each. There
is ample evidence that these domains mediate intra-
or intermolecular protein^protein interactions.
Although the similarity to zinc ¢ngers might suggest
so, there is no evidence for DNA binding by LIM
domains [117^119].
Human, rat, mouse and chicken LIMKs have been
found. They possess unique structural features when
compared to known protein kinases. Therefore,
LIMKs have already been thought to play a speci¢c
role in previously uncharacterized signaling path-
ways, since they were ¢rst identi¢ed. Human
LIMK1 tightly interacts with PKC-Q and -j ; the
LIM2 domain is critical for the binding between
LIMK1 and PKC-Q [120]. LIMK1 may negatively
regulate its catalytic function by interaction between
LIM and kinase catalytic domains; LIMK1 has also
been demonstrated to associate with LIMK2 [121].
LIMK1 has recently been shown to be involved in
the accumulation of actin ¢laments: LIMK1 is acti-
vated by Rac1 to phosphorylate and inactivate co¢-
lin, which, in its active state, promotes disassembly
of actin ¢laments [122,123]. Our laboratory has
cloned a cDNA encoding a structural homolog of
the LIMKs from D. discoideum (P.W. Schenk et
al., unpublished results), which is the ¢rst non-verte-
brate LIMK to be identi¢ed.
4.8. Protein kinase C
Protein kinase C (PKC) has diverse functions in
growth, di¡erentiation and the control of membrane
processes. The PKC family includes 11 individual
isoforms. All PKC isoforms consist of a regulatory
and a catalytic domain (Fig. 2B). There are four
conserved (C1^C4) and ¢ve variable (V1^V5) re-
gions. C1 and C2 regions are situated in the regula-
tory domain; the C3 and C4 regions are contained
within the catalytic domain. The regulatory domain
contains a pseudo-substrate site, which is involved in
blocking the kinase. The association between the
pseudo-substrate site and the C4 region results in
an inactive PKC conformation [124,125]. The C1 re-
gion has one or two cysteine-rich domains, which
form zinc ¢nger structures. These structures bind ac-
tivating compounds, such as the lipid DAG (diacyl-
glycerol) and the phorbol ester PMA (phorbol 12-
myristate 13-acetate, also named TPA, for 12-O-tet-
radecanoyl phorbol 13-acetate) [126]. The C2 region
is involved in the binding of Ca2 : its canonical form
is absent in Ca2-independent PKC isoforms [127].
This region also contains a so-called ‘pseudo-anchor-
ing site’. This site is involved in the regulation of
PKC binding to receptors for activated C-kinase
(RACKs). RACKs are localized in the particulate
fraction and bind to the C2 region of activated
PKC. These components are important in regulating
PKC function: the inhibition of RACK^PKC inter-
actions disrupts PKC activation [128]. The pseudo-
anchoring site binds to the RACK binding site,
which contributes to the formation of an inactive
PKC conformation [129]. Several anchoring proteins,
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which assist in keeping PKCs inactive (RICKs, for
receptors for inactive C-kinase), are also thought to
play their parts. PKC’s isozyme speci¢city seems to
be partly mediated by association of each isoform
with speci¢c RICKs and RACKs [130]. PKC’s C3
and C4 regions comprise the 12 conserved kinase
subdomains: the C3 region contains the ATP bind-
ing site, while the C4 region is responsible for sub-
strate binding [125].
The presence of DAG causes a striking and selec-
tive increase in PKC’s a⁄nity for membranes, which
is accompanied by activation and pseudo-substrate
release. Membrane translocation is mediated by
DAG binding to the C1 domain and phosphatidyl-
serine binding to the C2 domain. For conventional
PKCs, the a⁄nity for acidic lipids is increased by
Ca2 [125]. Exploration of the time course of PKC’s
activation state under speci¢c cell stimulation is a
prerequisite for the clari¢cation of its physiological
roles. Very few studies have, however, succeeded in
the direct monitoring of its kinase activity in intact
cells. A method, that has therefore been used fre-
quently, is measuring the signal-dependent change
in the intracellular state of the protein. Most impor-
tantly, this involves redistribution of PKC, which is
often from the cytosol to the plasma membrane
[131].
Signals that stimulate GPCRs, RTKs or non-re-
ceptor PTKs can cause DAG production. PKC has
been shown to be rapidly activated by a transient rise
in DAG levels, resulting from PLC stimulation.
There is also a sustained increase in DAG and
PKC activity, which is thought to be the result of
(among others) phosphatidyl-choline hydrolysis by
phospholipase D [124,125,132]. Other lipid metabo-
lites, such as PIP3, can activate PKC as well. Several
PKC isotypes are activated independently in a redun-
dant manner through the PLC and the PI3K path-
way, which generate DAG and PIP3, respectively.
PKC-O activated via the PLC pathway translocates
to the cytoskeletal fraction, whereas that activated
via PI3K does not. This indicates a functional di¡er-
ence between PKC activated through di¡erent path-
ways [131].
Di¡erent PKC isozymes are also believed to have
distinct biological functions. On the basis of struc-
tural elements and activational characteristics, the
PKC family has been divided into three subfamilies.
PKC was originally identi¢ed as a phospholipid- and
calcium-dependent protein kinase [133]. PKC-K, -LI,
-LII and -Q are the members of the so-called ‘classi-
cal’ or ‘conventional PKC’ (cPKC) subfamily. These
kinases have two zinc ¢ngers in the C1 region and
are phosphatidyl-serine-, DAG- and Ca2-depend-
ent. They have a molecular mass of 77^78 kDa
[124]. For several years, it has been established that
PKC-K directly phosphorylates and activates the ser-
ine/threonine kinase Raf-1 in vitro and in vivo [134].
It is, however, still unclear how this phosphorylation
contributes to Raf activation. Although dominant
negative Ras expression can not block Raf-1 activa-
tion by signals that stimulate PKC, this activation
was recently reported to depend on the formation
of Ras-GTP^Raf-1 complexes [135]. PKC-K, -LI
and -Q speci¢cally inactivate GSK-3L by phosphory-
lation; this leads to derepression of the cJun tran-
scription factor [136]. The subfamily of non-classical
or novel PKCs (nPKCs) includes the N, O, R and a
isoforms. Their activity is only dependent on phos-
phatidyl-serine and DAG; it is independent of Ca2.
The nPKCs have a molecular mass of approximately
80 kDa [124]. Like PKC-K, PKC-N and -O have been
suggested to activate the MEK^ERK pathway via
Raf [137,138]. PKC-a has recently been shown to
synergize with the Ca2-dependent phosphatase cal-
cineurin to stimulate JNK1 via Rac1 [139]. The re-
lated sequence PKC-W/protein kinase D is also acti-
vated by DAG in the absence of Ca2. The 115-kDa
PKC-W protein contains an insert of 74 amino acids
between the two zinc ¢ngers of the C1 region, which
is associated with ine⁄cient phorbol ester binding
and apparently constitutive in vitro kinase activity.
It has two unique N-terminal hydrophobic domains
and lacks a typical pseudo-substrate site. Taken to-
gether, its characteristics place PKC-W somewhere
between the novel and the atypical PKCs [140].
The remaining PKC isoforms (j and S/V) are placed
in the subfamily of the atypical PKCs (aPKCs). The
aPKCs have a molecular mass of approximately 67
kDa. They lack the canonical C2 region and one of
the cysteine-rich domains in the C1 region. This re-
sults in DAG- and Ca2-independent PKCs
[124,132]. PKC-j and -S/V can be activated by PIP3
[141,142]. A direct interaction between PKC-j and
Ras is required for the stimulation of ERKs by an-
giotensin II in vascular smooth muscle cells [143].
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Finally, both TPA-sensitive and -insensitive PKCs
play a role in the regulation of gene expression by
so-called ‘TPA response elements’ [142,144].
4.9. Mitogen-activated protein kinases
The mitogen-activated protein kinases (MAPKs)
form a family of well-conserved serine/threonine kin-
ases, with a molecular mass of 38^55 kDa [79]. Mem-
bers of the MAPK family have a central role in a
wide variety of protein kinase cascades. These cas-
cades are found in all eukaryotic organisms and con-
sist of a three-kinase module that includes a MAPK,
a MAPK kinase (MAPKK) and a MAPK kinase
kinase (MAPKKK): the MAPK is activated by a
MAPKK, which is in turn activated by a MAPKKK
(Fig. 3). Stimulation of MAPKs often results in tran-
scriptional activation [145]. MAPKs are grouped on
the basis of sequence similarity, mechanism of up-
stream regulation and sensitivity to activation by dif-
ferent MAPKKs. Until recently, the MAPK family
was just subdivided into three subfamilies: the ERK
(extracellular signal regulated kinase), the SAPK/
JNK (stress-activated protein kinase/cJun N-terminal
kinase) and the p38 subfamily. The most studied
subfamily is that including ERK1 (42 kDa) and
ERK2 (44 kDa). These are involved in cascades con-
sisting of Raf, MEK1a/MEK2 and ERK1/ERK2 iso-
forms. Raf is in turn activated by a dynamic combi-
nation of phosphorylation (by PKC and/or other
protein kinases) and interactions with Ras-GTP
and 14-3-3 proteins [108]. The Raf^MEK^MAPK/
ERK pathway has e¡ects in non-proliferating cells,
but mitogenic signals especially stimulate the path-
way; proliferation can be blocked by inhibiting it.
The SAPKs/JNKs and the p38 subfamily kinases
mediate responses to cellular stress. During the last
few years, genes encoding novel MAPKs, such as
ERK5 and ERK6, have been cloned from verte-
brates. ERK5, ERK6 and the previously identi¢ed
kinase ERK3 are probably not regulated like the
members of the three subfamilies mentioned. This
suggests the existence of more MAPK pathways in
metazoans than was originally realized [146]. ERK5
was recently shown to mediate a Ras-dependent,
Raf-independent pathway activating the transcrip-
tion factor cMyc (which is also a substrate for
ERK1 and ERK2) [147].
In S. cerevisiae, there are six MAPKs. Five of
these have been associated with biological responses
to speci¢c stimuli. Inappropriate cross-talk is, for
instance, precluded by Fus3p. This MAPK channels
GL/Q-dependent signals from the pheromone ligand
through the mating pathway and prevents the signal
from activating ¢lamentation di¡erentiation via the
Kss1p MAPK [148]. The yeast probably uses Ste5p
as a sca¡old for the Ste11p^Ste7p^Fus3p cascade
complex [149]. Interestingly, functional binding be-
tween GL and the LIM domain-like region of
Ste5p has recently also been demonstrated to be re-
quired for the activation of Ste11p (Fig. 3) [150].
The vertebrate Ras^Raf^MEK^MAPK/ERK
pathway can be switched on by extracellular signal
molecules binding to either RTKs or GPCRs. One
activation mechanism involving GPCRs is mediated
by G-protein L/Q subunits stimulating Ras-GTP for-
mation [57,151]. The GPCR ligand angiotensin II
can, for instance, also stimulate ERK via a putative
Ras- and Raf-independent, PKC-dependent pathway
[152]. The members of the ERK subfamily have a
TEY motif in the activation segment between the
subdomain VII DFG and subdomain VIII APE con-
sensus sequences. MEK1a and MEK2 are able to
phosphorylate ERK1 and ERK2 on both threonine
and tyrosine in this TEY motif. The activating phos-
phorylation of these ERKs by these MEKs is highly
speci¢c and requires the native form of MAPK
[79,102]. The Ksr-1 (kinase suppressor of Ras 1) pro-
tein has been proposed to serve as a sca¡old for
MEK and ERK [153]. The dual phosphorylation
on TEY seems to be the main requirement for trans-
location of ERK1 and ERK2 to the nucleus; cata-
lytic MAPK activity is not required. Moreover,
phosphorylation induces ERK2 dimerization; this is
also necessary for its nuclear localization [154]. In-
terestingly, unlike the other MAPK family members,
ERK3 is constitutively nuclear [155].
Because of their broad range of substrate recogni-
tion, activated ERK1 and ERK2 can phosphorylate
a large number of proteins. Among the substrates of
these ERKs are transcription factors and other nu-
clear proteins (such as the ternary complex factor
Elk-1 and cMyc). In ¢broblasts, ERK1 and ERK2
promote entry into the cell cycle, at least in part, by
positively regulating the transcription of cyclin D1
[156]. Other substrates for these ERKs are upstream
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proteins of the MAPK cascade (such as the EGF
receptor and Raf-1); it is possible that phosphoryla-
tion by ERK serves as a feedback mechanism for the
upstream components that ¢nally activate it. Yet an-
other group of substrates is formed by downstream
protein kinases, such as p90rsk (RSK, for ribosomal
S6 kinase) and MAPKAP2. Finally, an important
group of ERK1 and ERK2 substrates consists of
cytoskeletal elements (such as MAP-1 and MAP-2).
About half of the ERKs in activated cells are bound
to the cytoskeleton. Also, a basal ERK activity is
required for the maintenance of cell^matrix interac-
tion in preference to cell^cell contacts. These ¢ndings
support the idea that ERKs are involved in cyto-
skeletal reorganization [102,157,158].
Mitogens and many types of stress (e.g. cyclohex-
imide, UV irradiation and heat shock) can stimulate
SAPK/JNK subfamily kinases. A de¢ning property
of SAPKs/JNKs is that, instead of the motif TEY on
ERKs, they contain the sequence TPY; this must
also be phosphorylated on both threonine and tyro-
sine for activation [79]. SAPK/JNK subfamily kin-
ases are activated by SEK1 (also named MKK4,
for MAPK kinase 4) and the recently identi¢ed
MAPK kinase 7 (MKK7); SEK1 can in turn be
phosphorylated and activated by MEKKs and other
kinases (Fig. 3) [103,146,159]. The transcription fac-
tors cJun, Elk-1 and ATF-2 serve as physiological
substrates for the SAPKs; SAPK phosphorylation
promotes transactivation [105]. ERK and SAPK/
JNK often have opposite roles in the regulation of
apoptosis. In many cell systems (such as PC12 cells),
ERK is thought to be protective and SAPK/JNK to
be facilitative; in other systems (such as B-cells), this
is believed to be the other way round [160,161].
p38 is a homolog of the Saccharomyces Hog1p
(high osmolarity glycerol response 1) protein. It is
de¢ned by the sequence TGY (instead of TEY or
TPY) in the activation segment. p38 and the mem-
bers of the ERK and SAPK/JNK subfamilies can all
be stimulated by hyperosmolarity stress [79]. p38 is
phosphorylated by MKK3 and MKK6. MAPKKs of
the SAPK/JNK and p38 cascades are, for instance,
activated by MTK1 (MAP three kinase 1) and TAK1
(TGF-L activated kinase 1) (Fig. 3) [146,162,163].
Among the substrates of p38 is MAPKAP2, which
in turn phosphorylates the heat shock protein Hsp25/
Hsp27; this con¢rms the role of the p38 cascade in
responding to stress [79]. In ¢broblasts, p38 antago-
nizes ERK1 and ERK2 by inhibiting the transcrip-
tion of cyclin D1 [156]. Recently, p38 was shown to
act as a component of the spindle assembly check-
point in somatic cell cycles [164]. In PC12 cells, p38
activation corresponds to the induction of apoptosis;
in primary myocardial cells, its activation is thought
to protect from apoptosis [165]. Taken together, the
e¡ects of ERK, SAPK/JNK and p38 modulation
appear to be largely dependent on the context in
which these components act. Nowadays, the ability
of cells to either survive or undergo apoptosis is
thought to be dictated by a critical balance between
several MAPK pathways. In a recent paper, Berra et
al. also postulated a regulating role for the PI3K-
protein kinase B/Akt survival module [166].
Dephosphorylation of MAPKs by speci¢c phos-
phatases plays a critical role in their inactivation.
An emerging family of dual speci¢city phosphatases
dephosphorylate both threonine and tyrosine resi-
dues in the TxY motif. These phosphatases include
CL100/MKP-1, PAC1, MKP-2 to MKP-5 and M3-6.
M3-6 and MKP-3 appear to be exceptional, in that
they seem to be able to discriminate between di¡er-
ent MAPKs. The M3-6 phosphatase displays speci¢c
inactivation of SAPK/JNK and p38 subfamily mem-
bers. MKP-3, on the other hand, selectively inacti-
vates ERK subfamily members. MKP-3 can be acti-
vated by speci¢c binding of ERK2 to its non-
catalytic N-terminus; this modulation is independent
of protein kinase activity [167^169].
5. Looking ahead
Signal transduction comprises the transmission of
extracellular signals to intracellular responses. Origi-
nally, the functions of signal transduction compo-
nents were mostly identi¢ed by simple enzyme^sub-
strate and gene expression analyses. From current
evidence, it is clear that phosphorylation and dephos-
phorylation by kinases and phosphatases play very
important roles during signal transmission processes.
As more and more information has become avail-
able, it is now, however, also evident that, in living
cells, complete dynamic networks of components
rather than separate cascades exist. At the same
time, an adequate level of signaling speci¢city has
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to be maintained. The latter is often essential to the
physiological roles of cells. In other words: cross-talk
is de¢nitely present, but, in many cases, has to be
minimized in order to obtain the right response at
the right time and place.
Of course, a considerable amount of speci¢city is
obtained by direct recognition of protein substrate
sites by kinases [73,80]. In addition, phylogenetic
analyses (such as that performed by Hanks and
Hunter [71]), the elucidation of ‘active’ crystal struc-
tures (such as those of PKA and ERK2 [73,78]), two-
hybrid screens [170], co-immunoprecipitation experi-
ments (such as those performed by Brady-Kalnay et
al. [13]) and overlay assays have demonstrated the
presence of an ever-growing number of interactions
and interaction motifs for many signal transduction
components. Examples of these motifs are SH2 and
other PY binding domains, proline-rich sequence
binding SH3 domains (such as that present in Src),
so-called ‘pleckstrin homology domains’ (such as
those in Sos and IRS-1) [3], LIM domains and so-
called ‘PDZ’ (for PSD-95/Dlg/ZO-1 homology) do-
mains [171].
In the ¢rst place, several interactions between sig-
nal transduction and cytoskeletal components (which
may assure correct localization) have been described.
In many other cases we mentioned above, transmis-
sion molecules, which are often modi¢ed themselves,
constitute docking sites or sca¡olds for other com-
ponents or complexes. Yet another nice example is
provided by the Drosophila InaD protein, which ba-
sically consists of ¢ve PDZ domains. InaD serves as
a sca¡old to assemble di¡erent components of a pho-
totransduction cascade. It is believed that its PDZ
domains function as key elements in the organization
of transduction complexes in vivo [171]. Other mech-
anisms to obtain higher speci¢city do, of course, also
exist. The pathway-dedicated yeast MAPK Fus3p is,
for instance, thought to impart speci¢city by simply
channeling a particular signal through the right path-
way; by doing so, it prevents the signal from activat-
ing another [148].
Also, simple ligand^receptor interactions are often
not enough to activate underlying cascades. The re-
ceptor-like protein tyrosine phosphatase-L is, for ex-
ample, assumed to be activated by lateral mobility of
speci¢c ligands: this induces formation of monomers
from inactive dimers [172]. Receptor clustering (such
as that of integrins [33,34]) can be essential as well.
In general, a combination of sensitivity and wide
dynamic range of response is obtained if a cell has
both clusters and single receptors on its surface, es-
pecially if the propagation of the signal can adapt to
external conditions [173].
Much of the current knowledge has been obtained
using in vitro approaches and transfected cell lines.
Taken together, the re£ections above lead to the no-
tion that an adequate picture of signal transduction
by, for example, protein kinases, has to be obtained
from living cells, which have been manipulated as
little as possible. The use of model organisms, such
as Saccharomyces and Dictyostelium, can be of great
value: they potentially provide true in vivo situa-
tions. Modern imaging techniques, like those em-
ploying green £uorescent protein [174] and its deriv-
atives (which are shifted in their excitation and
emission spectra), will also prove very valuable
when analyzing localization and interactions of pro-
teins. The combined use of such systems and meth-
ods will greatly contribute to a better understanding
of how signal transduction components work in the
dynamic environment of intact cells.
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